Annual Meeting: March 15 – 19, 2020
ToxExpo: March 16 – 18, 2020
Anaheim Convention Center, Anaheim, California
High attrition rates in clinical trials is an indication that current testing is failing to predict safety/efficacy of compounds. NeuCyte supports the early phases of drug discovery programs as well as the investigation of MOAs for experimental compounds. Based on the SynFire® technology, our human neural invitro platforms are uniquely suited for assessing relevant higher order electrophysiology readouts which allow for a better predictor of drug efficacy and potential CNS Safety/Toxicology.
@ToxExpo on Twitter
11190 Sunrise Valley Dr, Ste 300, Reston, VA 20191
Exhibit Space and Rates
Request a Booth
Exhibitor Service Center
Anaheim Convention Center
800 W Katella Ave
Anaheim, CA 92802
Copyright 2018, a2z, Inc. All rights reserved.